Highlights

ASCO 2026 May 30th Program Highlights: Immunotherapy Advances in Solid Tumors

The ASCO 2026 May 30th program focused on immunotherapy in solid tumors, presenting data on novel combinations and biomarker-driven strategies.

ASCO 2026 May 29th Program Highlights: Novel Oncology Therapies

The ASCO 2026 May 29th program focused on advancements in targeted therapies and immunotherapies across various cancer types, presenting data on efficacy and safety.

Immunotherapy and Targeted Therapy: New Data from ASCO 2026

New research from ASCO 2026 explores combination strategies for advanced cancers and a machine learning approach to immunotherapy target discovery.

Epigenetic Modifications Link Genes to Health Outcomes

Scientists link genetics to health through epigenetic modifications, specifically DNA methylation and histone deacetylases, influencing disease.

Yoga Reduces Insomnia, Fatigue, Anxiety in Cancer Survivors

A new study presented at ASCO 2026 demonstrates yoga significantly improves insomnia, fatigue, and anxiety in cancer survivors.

Biologics Offer Targeted Efficacy in Psoriasis Management

Biologic therapies have significantly advanced psoriasis treatment by targeting specific immune pathways, offering improved outcomes for patients.

CAR T-Cell Therapy Shows Efficacy in Refractory Autoimmune Disease

CAR T-cell therapy, traditionally for cancer, demonstrates potential in severe autoimmune conditions, offering a new therapeutic avenue.

Antihypertensive Use Linked to Higher Fall Risk Across Patient Groups

Antihypertensive medications are associated with an increased fall risk across various patient demographics, necessitating careful risk-benefit assessment.

Myasthenia Gravis in Pregnancy: Exacerbations Common in Peripartum

Myasthenia gravis (MG) in pregnancy presents diagnostic and management challenges, with exacerbations common in the first trimester and postpartum period.

mRNA Shot Shows Efficacy Against Influenza-Like Illness

An mRNA vaccine demonstrated efficacy against influenza-like illness, offering a potential new approach to seasonal respiratory virus prevention.

Alternaria Allergy in Youth Signals Persistent Asthma Risk

Early sensitization to Alternaria alternata in children and adolescents is a significant predictor of asthma persistence into adulthood.

FDA Approves OTC Switch for Topical Adapalene 0.1% Gel

The FDA has approved the first over-the-counter retinoid, adapalene 0.1% gel, for acne treatment, expanding access to a previously prescription-only therapy.

Cataract Surgery: 4 Underappreciated Clinical Considerations

Cataract surgery, while common, presents nuances often overlooked in routine practice. This article details four less-known aspects.

COVID Not Primary Driver of Pediatric Type 1 Diabetes Rise

Evidence suggests the observed increase in pediatric type 1 diabetes predates the COVID-19 pandemic, indicating other factors are at play.

ASCO 2026: Anticipating Advances in Oncology Treatment

ASCO 2026 is expected to highlight progress in targeted therapies, immunotherapy, and precision oncology, with a focus on biomarker-driven treatment strategies.

EASL Congress 2026: Key Trials to Watch in Liver Disease Management

EASL Congress 2026 will feature pivotal trials in NAFLD/NASH, HBV, and HCC, potentially reshaping current treatment paradigms.

CGRP Inhibitors for Migraine: CV Safety Data Limited in High-Risk Patients

CGRP-targeted therapies are effective for migraine prevention, but cardiovascular safety data is limited in patients with established vascular disease.

Amyloid Therapies Show Limited Cognitive Benefit in AD

Current pharmacological therapies for Alzheimer's disease offer symptomatic relief but do not halt or reverse disease progression.

Ebola Pandemic Risk in 2026: A Low Probability Assessment

An Ebola pandemic in 2026 is considered unlikely due to established public health responses, vaccine availability, and improved surveillance.

Tirzepatide: Efficacy in Weight Management Explored at ATS 2026

Tirzepatide, a dual GIP/GLP-1 receptor agonist, demonstrates significant efficacy in chronic weight management, offering a new therapeutic option.

Eosinophilic Disorders: Best Practices for HES and EGPA at ATS 2026

Managing hypereosinophilic syndrome (HES) and eosinophilic granulomatosis with polyangiitis (EGPA) presents diagnostic and therapeutic challenges.

Next-Gen Extracellular Vesicles: Biomarkers, Targets, Deliverables in Oncology

Extracellular vesicles (EVs) and particles (EPs) offer new avenues for cancer diagnosis, prognosis, and therapy. Their role as biomarkers and drug delivery systems is expanding.

Cancer Therapies Induce Lifespan Comorbidities: ACCR 2026 Review

Cancer therapies, while life-saving, induce significant long-term comorbidities across all age groups, necessitating integrated survivorship care.

IVUS Guidance Improves PCI Outcomes in Complex Bifurcation Lesions

Intravascular ultrasound (IVUS) guidance for percutaneous coronary intervention (PCI) in complex bifurcation lesions demonstrated superior outcomes compared to angiography guidance.

Late-Onset Genetic Cholestasis: Underdiagnosis in Adults Examined

Late-onset genetic cholestatic diseases are frequently missed in adults, leading to delayed diagnosis and suboptimal management. Increased awareness is critical.

EASL 2026 Consensus: AATD-Liver Disease Management Standardised

A new consensus statement from EASL 2026 aims to standardise the diagnosis and management of Alpha-1 Antitrypsin Deficiency (AATD) related liver disease.

PARP1 Deficiency Reduces Amyloid Pathology in Familial AD Model

New preclinical work links PARP1 deficiency to reduced amyloid burden and cognitive preservation in a familial Alzheimer's model.

Early Breast Cancer at ASCO 2026: Trials to Watch

ASCO 2026 is expected to bring pivotal data on adjuvant and neoadjuvant strategies in early breast cancer. Here is what clinicians should watch for.

Lower-Dose Tirzepatide: Can It Sustain Weight Loss Long-Term?

New evidence examines whether reduced tirzepatide doses can maintain weight loss, with implications for long-term obesity management in primary care.

Brain Cooling After Thrombectomy: Does Hypothermia Aid LVO Recovery?

Targeted temperature management after mechanical thrombectomy for LVO stroke is under active investigation, but the evidence base remains preliminary.